(Q34322978)

1 August 2017

1 reference

title

Treatment of pain syndromes with venlafaxine (English)

1 reference

1 August 2017

Dale R Grothe

1

1 reference

1 August 2017

Brian Scheckner

series ordinal

2

1 reference

1 August 2017

Dominick Albano

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

1 August 2017

1 reference

1 August 2017

volume

24

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

621-629

1 reference

Symptoms in the community. Prevalence, classification, and psychiatric comorbidity.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Chronic pain and depression. II. Symptoms of anxiety in chronic low back pain patients and their relationship to subtypes of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Chronic pain and depression. I. Classification of depression in chronic low back pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

An international study of the relation between somatic symptoms and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Family study of affective spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Chronic pain, chronic stress and depression: coincidence or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Using chronic pain to predict depressive morbidity in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Chronic pain-associated depression: antecedent or consequence of chronic pain? A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

The use of antidepressants in the treatment of chronic pain. A review of the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Neuroanatomy of the pain system and of the pathways that modulate pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Venlafaxine in neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Treatment of neuropathic pain with venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

An open clinical trial of venlafaxine treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.621.34748

10.1592/PHCO.24.6.621.34748

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference